[1] 中华医学会内分泌学分会,中华医学会骨质疏松和骨矿盐疾病分会. 中国低血磷性佝偻病/骨软化症诊疗指南[J].中华骨质疏松和骨矿盐疾病杂志,2022,15(2):107-125.
[2] 周丽智,黄鑫,唐兰燕,等.肝性骨病发病机制的研究进展[J].中南医学科学杂志,2022,50(4):614-617.
[3] Peng Y, Xi S, Huang R. Association between hepatitis B virus infection and risk of osteoporosis:a systematic review and meta-analysis[J].Asian J Surg,2023,46(10):4598-4600.
[4] Jørgensen N R, Diemar S S, Christensen G L, et al.Patients with cirrhosis have elevated bone turnover but normal hepatic production of osteoprotegerin[J].J Clin Endocrinol Metab,2022,107(3):e980-e995.
[5] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2022)[J].中国全科医学,2023,26(14):1671-1691.
[6] Jeong H M, Kim D J. Bone diseases in patients with chronic liver disease[J]. Int J Mol Sci,2019,20(17):4270.
[7] Vaibhav S,Jalees F, Zeba S,et al. Study of correlation of bone mineral density with severity of liver cirrhosis[J].J Assoc Physicians India,2023,71(6):11-12.
[8] Olmos-Martínez J M,Hernández J L,Fábrega E,et al.Bone mineral density and trabecular bone score in treatment-na?ve patients with non-cirrhotic hepatitis C virus infection[J]. Arch Osteoporos,2020,15(1):72.
[9] Ehnert S, Aspera-Werz R H, Ruo? M, et al. Hepatic osteodystrophy- molecular mechanisms proposed to favor its development[J].Int J Mol Sci,2019,20(10):2555.
[10] Orsini L G,Pinheiro M M,Castro C H,et al.Bone mineral density measurements, bone markers and serum vitamin D concentrations in men with chronic non-cirrhotic untreated hepatitis C[J]. PLoS One, 2013, 8(11): e81652.
[11] Danford C J, Trivedi H D, Bonder A. Bone health in patients with liver diseases [J]. J Clin Densitom, 2020, 23(2 ):212-222.
[12] Peng Y, Xi S, Huang R. Association between hepatitis B virus infection and risk of osteoporosis:a systematic review and meta-analysis[J].Asian J Surg,2023,46(10):4598-4600.
[13] Oh H, Jun D, Lee I, et al. Increasing comorbidities in a South Korea insured population-based cohort of patients with chronic hepatitis B[J]. Aliment Pharmacol Ther, 2020,52(2): 371-381.
[14] Olmos-Martinez J M, Hernandez J L, Fabrega E, et al. Bone mineral density and trabecular bone score in treatmentnaïve patients with non-cirrhotic hepatitis C virus infection[J]. Arch Osteoporos, 2020,15(1): 72.
[15] Chen Y Y, Fang W H, Wang C C, et al. Crosssectional assessment of bone mass density in adults with hepatitis B virus and hepatitis C virus infection[J]. Sci Rep, 2019, 9(1): 5069.
[16] Danford C J,Trivedi H D, Papamichael K,et al.Osteoporosis in primary biliary cholangitis[J]. World J Gastroenterol,2018,24(31):3513-3520.
[17] Lin J C, Hsieh T Y, Wu C C,et al.Association between chronic hepatitis C virus infection and bone mineral density[J].Calcif Tissue Int, 2012, 91(6): 423-429.
[18] Ionele C M,Turcu-Stiolica A,Subtirelu M S,et al.A systematic review and meta-analysis on metabolic bone disease in patients with primary sclerosing cholangitis[J]. J Clin Med,2022,11(13):3807.
[19] Ehnert S,Aspera-Werz R H,Ruob M,et al.Hepatic osteodystrophy-molecular mechanisms proposed to favor its development[J]. Int J Mol Sci,2019,20(10): 2555.
[20] Jadzic J,Milovanovic P,Cvetkovic D,et al.Mechano-structural alteration in proximal femora of individuals with alcoholic liver disease:Implications for increased bone fragility[J]. Bone,2021,150(9):116020.
[21] Malik P,Gasser R W,Kemmler G,et al. Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study[J]. Alcohol Clin Exp Res,2009,33(2):375-381.
[22] 宋蒙胜,余宵,庞清江.失代偿肝硬化致骨质疏松症的发病机制及治疗研究进展[J].中华骨与关节外科杂志,2019,12(11):924-928.
[23] 王荣昌,甘露,王玉莹,等.牛初乳冻干粉和复合制剂对维甲酸所致小鼠骨质疏松症的预防和抗氧化作用[J].安徽农业科学,2021,49(10):157-160,163.
[24] 夏禹承,吴淑娟,张润光,等.果蔬复合固体饮料的制备及其对小鼠肝性骨病的预防作用[J].农业工程学报,2023,39(3):248-259.
[25] Aceto G M,Catalano T,Curia M C.Molecular aspects of colorectal adenomas: the interplay among microenvironment, oxidative stress,and predisposition[J]. Biomed Res Int,2020,2020:1726309.
[26] Stacchiotti V,Rezzi S,Eggersdorfer M,et al.Metabolic and functional interplay between gut microbiota and fat-soluble vitamins[J]. Crit Rev Food Sci Nutr,2021,61(19):3211-3232.
[27] Lips P.Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications[J]. Endocr Rev,2001,22(4),477-501.
[28] Macdonald H M, Reid I R, Gamble G D,et al. 25-Hydroxyvitamin D threshold for the effects of vitamin D supplements on bone density:secondary analysis of a randomized controlled trial[J].J Bone Miner Res,2018,33(8):1464-1469.
[29] Luo M, Xu Y, Li J,et al.Vitamin D protects intestines from liver cirrhosis-induced inflammation and oxidative stress by inhibiting the TLR4/MyD88/NF-κB signaling pathway[J].Open Med (Wars),2023,18(1):20230714.
[30] Malaguarnera L. Vitamin D and microbiota:two sides of the same coin in the immunomodulatory aspects[J].Int Immunopharmacol,2020,79(2): 106112.
[31] Lee P C,Hsieh Y C,Huo T L,et al.Active vitamin D3 treatment attenuated bacterial translocation via improving intestinal barriers in cirrhotic rats[J].Mol Nutr Food Res,2021,65(3):e2000937.
[32] Sarkar M,Lai J C,Sawinski D,et al.Sex hormone levels by presence and severity of cirrhosis in women with chronic hepatitis C virus infection[J].J Viral Hepat,2019,26(2):258-262.
[33] 《中国骨质疏松杂志》骨代谢专家组.骨代谢生化指标临床应用专家共识(2023修订版)[J].中国骨质疏松杂志,2023,29(4):469-476.
[34] Triantos C,Kalafateli M,Aggeletopoulou I,et al.Vitamin D-related immuno-modulation in patients with liver cirrhosis[J]. Eur J Gastroenterol Hepatol,2020,32(7):867-876.
[35] Fakhoury H M A,Kvietys P R,AlKattan W,et al.Vitamin D and intestinal homeostasis: Barrier,microbiota, and immune modulation[J].J Steroid Bioche Mol Biol,2020,200(7):105663.
[36] Liu C,Kuang X,Li K,et al.Effects of combined calcium and vitamin D supplementation on osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials[J].Food Funct,2020,11(12):10817-10827.
[37] Jørgensen J O L,Johannsson G,Barkan A.Should patients with adult GH deficiency receive GH replacement?[J].Eur J Endocrinol, 2021,186(1):D1-D15.
[38] Hejazi J,Davoodi A, Khosravi M,et al.Nutrition and osteoporosis prevention and treatment[J].Biomed Res Ther,2020,7,3709-3720.
[39] Kanis J A,Cooper C,Rizzoli R,et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women[J].Osteoporos Int, 2019,30(1): 3-44.
[40] 肖慧娟,韩涛.肝硬化患者营养不良、肌肉减少症及骨质疏松的防治[J].临床肝胆病杂志,2021,37(1):26-30.
[41] 孙龙飞,陈迎锋,卜文倩,等.Irisin 在运动调节骨代谢中的作用机制[J].体育科技文献通报,2021,29(10):197-199.
[42] 叶蓁蓁,易剑锋,潘建西.运动与绝经后女性骨强度、体成分及性激素的关系[J].解剖学报,2021,52(3) : 473-478.
[43] Siqueira M M L G, Casulari L A, Freitas W M,et al.Risk factors associated with fracture of the lumbosacral spine and its compromise in the quality of life of cirrhotics[J]. Arq Gastroenterol,2022,59(1):9-15. |
